Amino Acids as Targets for Immunotherapy against Solid Tumors

Paoletti, A., Courtney-Martin, G., & Elango, R. (2024). Determining amino acid requirements in humans. Frontiers in Nutrition, 11, 1400719 https://doi.org/10.3389/fnut.2024.1400719.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reeds, P. J. (2000). Dispensable and indispensable amino acids for humans. The Journal of Nutrition, 130(7), 1835S–40S. https://doi.org/10.1093/jn/130.7.1835S.

Article  CAS  PubMed  Google Scholar 

Aliu, E., Kanungo, S., & Arnold, G. L. (2018). Amino acid disorders. Annals of Translational Medicine, 6(24), 471 https://doi.org/10.21037/atm.2018.12.12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kelly, B., & Pearce, E. L. (2020). Amino assets: How amino acids support immunity. Cell metabolism, 32(2), 154–175. https://doi.org/10.1016/j.cmet.2020.06.010.

Article  CAS  PubMed  Google Scholar 

Knott, S. R. V., Wagenblast, E., Khan, S., Kim, S. Y., Soto, M., Wagner, M., Turgeon, M. O., Fish, L., Erard, N., Gable, A. L., Maceli, A. R., Dickopf, S., Papachristou, E. K., D’Santos, C. S., Carey, L. A., Wilkinson, J. E., Harrell, J. C., Perou, C. M., Goodarzi, H., & Hannon, G. J. (2018). Asparagine bioavailability governs metastasis in a model of breast cancer. Nature, 554(7692), 378–381. https://doi.org/10.1038/nature25465. Epub 2018 Feb 7. Erratum in: Nature. 2018 Apr 4;556(7699):135. 10.1038/nature26162PMID: 29414946; PMCID: PMC5898613.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Linden, M. A., Teixeira, T. L. M., Freitas, R. G. B. O. N., Brandão, M. Â. B., & Nogueira, R. J. N. (2022). Arginine and glutamine supplementation on transthyretin levels in severely burned patients: A systematic review. Nutrition, 101, 111657 https://doi.org/10.1016/j.nut.2022.111657.

Article  CAS  PubMed  Google Scholar 

Ward, P. S., & Thompson, C. B. (2012). Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell, 21(3), 297–308. https://doi.org/10.1016/j.ccr.2012.02.014.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng, Y., Yao, Y., Ge, T., Ge, S., Jia, R., Song, X., & Zhuang, A. (2023). Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity. Journal of Experimental and Clinical Cancer Research, 42(1), 291 https://doi.org/10.1186/s13046-023-02845-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020). Metabolic reprogramming and cancer progression. Science, 368(6487), eaaw5473 https://doi.org/10.1126/science.aaw5473.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, J., Cui, L., Lu, S., & Xu, S. (2024). Amino acid metabolism in tumor biology and therapy. Cell Death & Disease, 15(1), 42 https://doi.org/10.1038/s41419-024-06435-w.

Article  Google Scholar 

Wang, W., & Zou, W. (2020). Amino acids and their transporters in t cell immunity and cancer therapy. Molecular Cell, 80(3), 384–395. https://doi.org/10.1016/j.molcel.2020.09.006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Do, L. K., Lee, H. M., Ha, Y. S., Lee, C. H., & Kim, J. (2025). Amino acids in cancer: Understanding metabolic plasticity and divergence for better therapeutic approaches. Cell Reports, 44(4), 115529 https://doi.org/10.1016/j.celrep.2025.115529.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang, L., Chu, Z., Liu, M., Zou, Q., Li, J., Liu, Q., Wang, Y., Wang, T., Xiang, J., & Wang, B. (2023). Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy. Journal of Hematology & Oncology, 16(1), 59 https://doi.org/10.1186/s13045-023-01453-1.

Article  CAS  Google Scholar 

Ge, M., Xu, Y., Cui, L., Huang, E., Liu, Z., & Yin, K. (2025). Targeting amino acid in tumor therapy. Frontiers in Oncology, 15, 1582116 https://doi.org/10.3389/fonc.2025.1582116.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ansari, R. E., Craze, M. L., Althobiti, M., Alfarsi, L., Ellis, I. O., Rakha, E. A., & Green, A. R. (2020). Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer. British Journal of Cancer, 122(1), 94–101. https://doi.org/10.1038/s41416-019-0626-z.

Article  CAS  PubMed  Google Scholar 

Lu, Y., Jiang, Z., Wang, K., Yu, S., Hao, C., Ma, Z., Fu, X., Qin, M. Q., Xu, Z., & Fan, L. (2022). Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer. BMC Cancer, 22(1), 833 https://doi.org/10.1186/s12885-022-09935-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanarek, N., Petrova, B., & Sabatini, D. M. (2020). Dietary modifications for enhanced cancer therapy. Nature, 579(7800), 507–517. https://doi.org/10.1038/s41586-020-2124-0.

Article  CAS  PubMed  Google Scholar 

Lorvik, K. B., Hammarström, C., Fauskanger, M., Haabeth, O. A., Zangani, M., Haraldsen, G., Bogen, B., & Corthay, A. (2016). Adoptive transfer of tumor-specific Th2 cells eradicates tumors by triggering an in situ inflammatory immune response. Cancer Research, 76(23), 6864–6876. https://doi.org/10.1158/0008-5472.CAN-16-1219.

Article  CAS  PubMed  Google Scholar 

Rodriguez, P. C., Quiceno, D. G., & Ochoa, A. C. (2007). L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood, 109, 1568–73. https://doi.org/10.1182/blood-2006-06-031856.

Article  CAS  PubMed  Google Scholar 

Advani, S. H. (2010). Targeting mTOR pathway: A new concept in cancer therapy. Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology, 31(4), 132–6.

Article  CAS  Google Scholar 

Shi, H., Chapman, N. M., Wen, J., Guy, C., Long, L., Dhungana, Y., Rankin, S., Pelletier, S., Vogel, P., Wang, H., Peng, J., Guan, K. L., & Chi, H. (2019). Amino acids license kinase mTORC1 activity and Treg cell function via small G proteins Rag and Rheb. Immunity, 51(6), 1012–27.e7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Munn, D. H., & Mellor, A. L. (2013). Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends in Immunology, 34(3), 137–43.

Article  CAS  PubMed  Google Scholar 

Han, C., Ge, M., Ho, P. C., & Zhang, L. (2021). Fueling T-cell antitumor immunity: Amino acid metabolism revisited. Cancer. Immunologic Research, 9(12), 1373–82.

CAS  Google Scholar 

Walls, J., Sinclair, L., & Finlay, D. (2016). Nutrient sensing, signal transduction and immune responses. Seminars in Immunology, 28(5), 396–407.

Article  CAS  PubMed  Google Scholar 

Silva, R. C. M. C. (2024). mTOR-mediated differentiation and maintenance of suppressive T cells at the center stage of IPEX treatment. Immunologic Research. https://doi.org/10.1007/s12026-024-09472-x.

Article  PubMed  Google Scholar 

Ling, N. X. Y., Kaczmarek, A., Hoque, A., Davie, E., Ngoei, K. R. W., Morrison, K. R., Smiles, W. J., Forte, G. M., Wang, T., Lie, S., Dite, T. A., Langendorf, C. G., Scott, J. W., Oakhill, J. S., & Petersen, J. (2020). mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress. Nature Metabolism, 2(1), 41–49. https://doi.org/10.1038/s42255-019-0157-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ren, S., Zhou, X., Wang, Z., & Yuan, K. (2025). Amino acids metabolism: a potential target for cancer treatment. Molecular Cancer, 24(1), 307 https://doi.org/10.1186/s12943-025-02523-3.

Article  CAS  PubMed  PubMed Central 

Comments (0)

No login
gif